The interference of heparin on IEF-PAGE of erythropoietins

Drug Testing and Analysis

Volumn 2, Issue 11-12, 2010, Pages 568-575

  Reichel, Christian ^a   Benetka, Edmund ^a   Geisendorfer, Thomas ^a   Scheiblhofer, Veronika ^a   Abzieher, Friedrich ^a  

^a AIT Seibersdorf Laboratories   (Austria)

Author keywords

Doping control; Erythropoietin; Heparin; Isoelectric focusing; SDS PAGE

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; ELECTROPHORESIS; POLYSACCHARIDES;

ACETYLSALICYLIC ACIDS; ANTITHROMBIN III; DOPING CONTROL; ERYTHROPOIETIN; HEART ATTACK; HEPARIN; ISOELECTRIC FOCUSING; PLASMA PROTEIN; SDS-PAGE; UNFRACTIONATED HEPARINS;

UREA;

HEPARAN SULFATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT ERYTHROPOIETIN; UREA;

ANTIBODY AFFINITY; ARTICLE; DOPING; HUMAN; ISOELECTRIC FOCUSING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; URINE RETENTION;

EID: 78650650468     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.182     Document Type: Article

References (46)

1. A. Carlsson, in Essential Guide to Blood Coagulation, (Eds: M. Blombäck, J. P. Antovic), Wiley-Blackwell: Chichester, UK, 2010, pp. 67-90.
2. B. Kemkes-Matthes, G. Oehler, Blutgerinnung und Thrombose, Georg Thieme Verlag: Stuttgart, 2001, pp. 3-5.
3. D. Hoppensteadt, O. Iqbal, J. Fareed, in Chemistry and Biology of Heparin and Heparan Sulfate, (Eds: H. G. Garg, R. J. Linhardt, C. A. Hales), Elsevier: Amsterdam, 2005, pp. 583-606.
4. T. T. Horlocker, J. A. Heit, Anesth. Analg. 1997, 85, 874.
5. B. Casu, in Chemistry and Biology of Heparin and Heparan Sulfate, (Eds: H. G. Garg, R. J. Linhardt, C. A. Hales), Elsevier: Amsterdam, 2005, pp. 1-28.
6. S. A. Mousa, in Chemistry and Biology of Heparin and Heparan Sulfate, (Eds: H. G. Garg, R. J. Linhardt, C. A. Hales), Elsevier: Amsterdam, 2005, pp. 571-581.
7. G. Hiendlmayer, Gerinnungshemmer, Kohlhammer: Stuttgart, 2007, pp. 32-33.
8. H.-J. Schäfer, W. Schänzer, U. Schwabe, Abschlussbericht der Expertenkommission zur Aufklärung von Dopingvorwürfen gegenüber Ärzten der Abteilung Sportmedizin des Universitätsklinikums Freiburg, Stabsstelle Presse- und Öffentlichkeitsarbeit Universitätsklinikum Freiburg, Cologne, 2009, pp. 15-16.
9. P. G. Righetti, A. V. Stoyanov, M. Y. Zhukov, The Proteome Revisited, Elsevier: Amsterdam, 2001, pp. 162-164.
10. I. Capila, R. J. Linhardt, Angew. Chem. Int. Ed. 2002, 41, 390.
11. H. E. Conrad, Heparin-Binding Proteins, Academic Press: San Diego, 1998, pp. 421-422.
12. J. J. Oppenheim, M. Feldmann, in Cytokine Reference (Eds: J. J. Oppenheim, M. Feldman, S. K. Durum, T. Hirano, J. Vilcek, N. A. Nicola), Academic Press: San Diego, 2001, p. 9.
13. F. Zhang, Z. Zhang, R. J. Linhardt, in Handbook of Glycomics, (Eds: R. D. Cummings, J. M. Pierce), Academic Press: Amsterdam, 2009, pp. 59-80.
14. Sanofi-Aventis, Lovenox® Prescribing Information, 2009, Available at: [27 June 2010].
15. Gerot Pharmazeutika, Ivor® 2500 I.E. Prescribing Information, 2006, Available at: [27 June 2010].
16. Ebewe Pharma, Depot-Heparin Immuno® Prescribing Information, 2004, Avialable at: [27 June 2010].
17. I. Bajla, I. Holländer, M. Minichmayr, G. Gmeiner, C. Reichel, Comput. Methods Programs Biomed. 2005, 80, 246.
18. F. Lasne, L. Martin, N. Crepin, J. de Ceaurriz, Anal. Biochem. 2002, 311, 119.
19. MAIIA Diagnostics, in EPO Purification Kit Directions for Use (0250), Uppsala, 2010, Available at: [27 June 2010].
20. R. Westermeier, Electrophoresis in Practice, Wiley-VCH Verlag: Weinheim, 2005, pp. 14, 178.
21. D. M. Bollag, M. D. Rozycki, S. J. Edelstein, Protein Methods, Wiley-Liss: New York, 1996, p. 180.
22. C. Reichel, F. Abzieher, T. Geisendorfer, Drug Test. Analysis 2009, 1, 494.
23. Invitrogen, in NuPAGE Technical Guide Version E (IM-1001), Carlsbad, 2003, pp. 12-16.
24. R. P. Estrella, J. M. Whitelock, R. H. Roubin, N. H. Packer, N. G. Karlsson, in Methods in Molecular Biology, Glycomics: Methods and Protocols, Vol. 534, (Eds: N. H. Packer, N. G. Karlsson), Humana Press: New York, 2009, pp. 171-192.
25. N. M. McDuffie, C. P. Dietrich, H. B. Nader, Biopolymers 1975, 14, 1473.
26. C. P. Dietrich, H. B. Nader, N. M. McDuffie, An Acad. Bras. Cienc. 1975, 47, 301.
27. E. A. Johnson, B. Mulloy, Carbohydr. Res. 1976, 51, 119.
28. T. Berkelman, in Handbook of Isoelectric Focusing and Proteomics, (Eds: D. Garfin, S. Ahuja), Elsevier: Amsterdam, 2005, pp. 73-75.
29. P. G. Righetti, Isoelectric Focusing: Theory, Methodology and Applications, Elsevier: Amsterdam, 1983, pp. 308-311.
30. R. K. Murray, F. W. Keeley, in Harper's Illustrated Biochemistry (Eds: K. Murray, D. K. Granner, P. A. Mayes, V. W. Rodwell), McGraw-Hill: New York, 2003, p. 545.
31. B. Heintz, G. Stöcker, C. Mrowka, U. Rentz, H. Melzer, E. Stickeler, H. G. Sieberth, H. Greiling, H. D. Haubeck, Hypertension 1995, 25, 399.
32. T. J. Wijnhoven, J. F. Lensen, R. G. P. Wismans, M. Lamrani, L. A. Monnens, R. A. Wevers, A. L. Rops, J. van der Vlag, J. H. Berden, L. P. van den Heuvel, T. H. van Kuppevelt, J. Am. Soc. Nephrol. 2007, 18, 823.
33. T. J. Wijnhoven, J. F. Lensen, R. G. P. Wismans, D. J. Lefeber, A. L. Rops, J. van der Vlag, J. H. Berden, L. P. van den Heuvel, T. H. van Kuppevelt, J. Am. Soc. Nephrol. 2007, 18, 3119.
34. F. Lasne, in Pharmacology, Doping and Sports, (Ed: J. L. Fourcroy), Routledge: London, 2009, pp. 107-124.
35. S. Lamon, L. Martin, N. Robinson, M. Saugy, J. Ceaurriz, F. Lasne, Clin. J. Sport. Med. 2009, 19, 311.
36. World Anti-Doping Agency, 2009, 1-9. Available at: [27 June 2010].
37. L. M. Hiebert, S. M. Wice, T. Ping, J. Lab. Clin. Med. 2005, 145, 151.
38. E. Y. Lee, S. H. Kim, S. K. Whang, K. Y. Hwang, J. O. Yang, S. Y. Hong, Am. J. Nephrol. 2003, 23, 152-
39. F. Maccari, D. Gheduzzi, N. Volpi, Clin. Chem. 2003, 49, 380.
40. Pharmacia Fine Chemicals, Isoelectric Focusing: Principles and Methods, Pharmacia Fine Chemicals AB: Uppsala, 1982, pp. 92-93.
41. J. McCarthy, F. Hopwood, D. Oxley, M. Laver, A. Castagna, P. G. Righetti, K. Williams, B. Herbert, J. Proteome Res. 2003, 2, 239.
42. M. Kohler, C. Ayotte, P. Desharnais, U. Flenker, S. Lüdke, M. Thevis, E. Völker-Schänzer, W. Schänzer, Int. J. Sports Med. 2008, 29, 1.
43. A. Lüdke, S. Lüdke, E. Völker-Schänzer, W. Schänzer, in Recent Advances in Doping Analysis (17), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck), Sportverlag Strauß: Köln, 2009, pp. 301-304.
44. F. Lasne, L. Martin, J. A. Martin, J. de Ceaurriz, Int. J. Biol. Macromol. 2007, 41, 354.
45. M. Schuste, E. Wasserbauer, A. Neubauer, A. Jungbauer, Bioseparation 2000, 9, 259.
46. MAIIA Diagnostics, in EPO Purification Kit for urine and serum specimens, Uppsala, 2010, Available at: [27 June 2010].